Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
EnGene cancer sales forecast cut after new data widen gap to J&J
Leerink analysts slashed their forecast for enGene’s bladder cancer candidate after phase 2 data dented their belief that the biotech can match J&J.
Nick Paul Taylor
May 8, 2026 9:08am
Biopharma veteran takes her CEO Cue—Chutes & Ladders
May 8, 2026 8:30am
Carl Sailer on AI, market trends, and strategic planning in biotech
Brought to you by
Syneos Health
Odyssey CEO sees $304M IPO creating ‘little large pharma’
May 8, 2026 7:27am
Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization
Brought to you by
Guidehouse
Banyan BioInnovations launches with $100M, Icon collab
May 7, 2026 2:13pm
